BIOMAT Database Logo BIOMAT Database Logo

Very-low-density lipoprotein apolipoprotein B100 kinetics in adult hypopituitarism. 1999

A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Section of Endocrinology and Metabolic Medicine, Imperial College School of Medicine, St. Mary's Hospital, London, UK.

Hypopituitarism is associated with hyperlipidemia, the mechanisms of which are not fully known. One possible mechanism is an increased hepatic secretion of very-low-density lipoprotein (VLDL) apolipoprotein B100 (apo B100). To investigate this, 13 hypopituitary patients (seven women and six men; age, 46 +/- 3 years [mean +/- SEM]; body mass index [BMI], 29 +/- 2 kg/m2) and 13 matched controls (seven women and six men; age, 43 +/- 3 years; BMI, 28 +/- 2 kg/m2) were investigated in a stable-isotope study. [1-(13)C]leucine (1 mg/kg body weight) was administered, followed by a continuous 6-hour infusion of [1-(13)C]leucine (at a rate of 1 mg/kg/h). Patients had a similar fractional secretion rate (FSR) of VLDL apo B100 versus controls (0.37 +/- 0.05 v 0.38 +/- 0.06 pools/h, respectively), but they had a significantly larger pool size (3.4 +/- 0.3 v 1.9 +/- 0.3 mg/kg) and higher absolute secretion rate ([ASR] 27.8 +/- 2.9 v 16.0 +/- 2.5 mg/kg/d). The increase in hepatic VLDL production may explain the lipid abnormalities found in hypopituitarism. Fasting circulating nonesterified fatty acids (NEFAs) were decreased in the patients (284 +/- 26 v 664 +/- 92 micromol/L, P < .001) despite the increase in VLDL secretion. An inverse relationship was observed between the NEFA level and VLDL apo B100 FSR in the patients (r(s) = -.85, P < .005).

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007018 Hypopituitarism Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions. Adenohypophyseal Hyposecretion,Anterior Pituitary Hyposecretion Syndrome,Sheehan Syndrome,Simmonds Disease,Hyposecretion Syndrome, Anterior Pituitary,Hyposecretion, Adenohypophyseal,Pituitary Insufficiency,Postpartum Hypopituitarism,Postpartum Panhypopituitarism,Postpartum Pituitary Insufficiency,Sheehan's Syndrome,Simmonds' Disease,Disease, Simmonds,Hypopituitarism, Postpartum,Insufficiency, Pituitary,Panhypopituitarism, Postpartum,Pituitary Insufficiency, Postpartum,Sheehans Syndrome,Simmond's Disease,Syndrome, Sheehan,Syndrome, Sheehan's
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.
May 2014, Journal of biomedical research,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study.
January 1999, The Journal of clinical endocrinology and metabolism,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
January 2003, Metabolism: clinical and experimental,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Very low density lipoprotein subfraction apolipoprotein composition.
August 1993, Biochemical Society transactions,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Investigation of structural domains in human serum low density lipoprotein apolipoprotein B100.
January 1991, Advances in experimental medicine and biology,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
December 1975, The Journal of clinical investigation,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Very low density lipoprotein apolipoprotein B metabolism in humans.
August 1988, Klinische Wochenschrift,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Evidence for isomerization during binding of apolipoprotein-B100 to low density lipoprotein receptors.
January 1992, The Journal of biological chemistry,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope study.
April 2004, The Journal of clinical endocrinology and metabolism,
A Chrisoulidou, and E Kousta, and S Venkatesan, and R Gray, and P A Bannister, and J J Gallagher, and D G Johnston
Metabolic channelling of apolipoprotein B in very low density lipoprotein.
January 1984, Agents and actions. Supplements,
Copied contents to your clipboard!